NanoViricides, Inc. (NNVC)

USD 1.5

(0.67%)

Gross Profit Summary of NanoViricides, Inc.

  • NanoViricides, Inc.'s latest annual gross profit in 2024 was -759.01 Thousand USD , down -1.54% from previous year.
  • NanoViricides, Inc.'s latest quarterly gross profit in 2024 Q4 was -190.6 Thousand USD , down -0.34% from previous quarter.
  • NanoViricides, Inc. reported a annual gross profit of -747.52 Thousand USD in annual gross profit 2023, down -3.35% from previous year.
  • NanoViricides, Inc. reported a annual gross profit of -723.32 Thousand USD in annual gross profit 2022, down -2.67% from previous year.
  • NanoViricides, Inc. reported a quarterly gross profit of -190.6 Thousand USD for 2024 Q4, down -0.34% from previous quarter.
  • NanoViricides, Inc. reported a quarterly gross profit of -189.95 Thousand USD for 2024 Q3, down -0.33% from previous quarter.

Annual Gross Profit Chart of NanoViricides, Inc. (2024 - 2005)

Historical Annual Gross Profit of NanoViricides, Inc. (2024 - 2005)

Year Gross Profit Gross Profit Growth
2024 -759.01 Thousand USD -1.54%
2023 -747.52 Thousand USD -3.35%
2022 -723.32 Thousand USD -2.67%
2021 -704.53 Thousand USD -0.69%
2020 -699.72 Thousand USD -0.55%
2019 -695.91 Thousand USD -2.33%
2018 -680.05 Thousand USD -2.58%
2017 -662.95 Thousand USD -0.52%
2016 -659.54 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Gross Profit Comparison of NanoViricides, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 574.384%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -203.606%
Armata Pharmaceuticals, Inc. -29.24 Million USD 97.404%
Actinium Pharmaceuticals, Inc. -709 Thousand USD -7.054%
Azitra, Inc. 260.45 Thousand USD 391.423%
Can-Fite BioPharma Ltd. 743 Thousand USD 202.155%
Chromocell Therapeutics Corporation -2.57 Million USD 70.574%
Calidi Biotherapeutics, Inc. -1.25 Million USD 39.569%
CEL-SCI Corporation -3.95 Million USD 80.825%
iBio, Inc. -1.02 Million USD 25.95%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 109.173%
MAIA Biotechnology, Inc. - USD Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 94.333%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -536.25%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 109.614%
Oragenics, Inc. -15.45 Million USD 95.088%
BiomX Inc. -1.22 Million USD 38.191%
BiomX Inc. -1.22 Million USD 38.191%
Protalix BioTherapeutics, Inc. 42.51 Million USD 101.785%
Palatin Technologies, Inc. 4.39 Million USD 117.28%
Scorpius Holdings, Inc. -2.21 Million USD 65.755%